Sarah Katz Caffeine Safety Act

Bill Summary: Sarah Katz Caffeine Safety Act (HR 2511)

Overview

The Sarah Katz Caffeine Safety Act is a legislative proposal designed to increase transparency regarding caffeine content in foods, beverages, and dietary supplements. The bill aims to protect public health by requiring clearer labeling of caffeine levels, commissioning safety reviews for vulnerable populations, and investigating the marketing practices used to sell caffeinated products to children and adolescents.

Key Provisions

1. Enhanced Labeling Requirements

The bill introduces strict disclosure mandates for different types of food service and retail:

• Chain Restaurants (20+ Locations):
  • High Caffeine Warning: Any standard or temporary menu item (appearing <60 days/year) containing added caffeine and at least 150mg of total caffeine must display a "High caffeine" statement or symbol.
  • Quantity Disclosure: Menus and menu boards (including drive-throughs) must explicitly list the number of milligrams of caffeine in the item.
• Packaged Foods and Dietary Supplements:
  • Any product containing more than 10mg of caffeine must list:
    1. The exact number of milligrams of caffeine.
    2. Whether the caffeine is naturally occurring or added.
    3. An advisory statement noting that the recommended daily limit for healthy adults is 400mg (or another limit determined by the Secretary).

2. Safety Reviews and Research

The bill mandates two distinct scientific reviews to be completed within six months of enactment:
* FDA Review: The Commissioner of Food and Drugs will evaluate whether caffeine remains "Generally Recognized as Safe" (GRAS), specifically examining added caffeine, complex stimulant blends, and substances like guarana and taurine.
* NIH Review: The National Institutes of Health will study the effects of caffeine on vulnerable populations, including:
* Children and adolescents.
* Pregnant and breastfeeding women.
* Individuals with heart conditions, seizure disorders, or specific mental health conditions.
* Caffeine-sensitive individuals.

3. Public Education and Oversight

• Education Campaign: The HHS, FDA, and CDC will launch a public awareness campaign focusing on the dangers of overconsumption and the risks to vulnerable groups.
• GAO Study: The Comptroller General will conduct a study (due within 180 days) on how caffeinated beverages are marketed, with a specific focus on misleading claims and targeting of children/teens via social media and influencers.

Impact and Affected Parties

• Consumers: Will have greater visibility into the caffeine content of their food and drinks, allowing for more informed health decisions.
• Restaurant Chains: Large chains (20+ locations) will need to update their menus and digital boards to comply with new warning and disclosure requirements.
• Food/Supplement Manufacturers: Producers of any food or supplement with >10mg of caffeine will need to redesign packaging to include the new mandates.
• Federal Agencies: The FDA, NIH, and GAO will be tasked with significant new research and reporting obligations.

Financial and Procedural Details

• Funding: The bill authorizes $2 million in appropriations ($1 million for the FDA review and $1 million for the NIH review).
• Timeline: Reports from the FDA and NIH are due within 6 months, and the GAO marketing report is due within 180 days of the Act's passage.
• Current Status: As of March 31, 2025, the bill has been introduced and referred to the House Committee on Energy and Commerce.